A prospective retrospective study assessing predictive factors of acute variceal bleeding (AVB) and to monitor portal hypertension parameters under treatment
Latest Information Update: 15 Dec 2022
At a glance
- Drugs Atezolizumab (Primary) ; Bevacizumab (Primary)
- Indications Liver cancer
- Focus Adverse reactions
Most Recent Events
- 15 Dec 2022 New trial record
- 01 Dec 2022 Results published in the Liver International